Intellectual Property & Patents

FTC Bars Endo from Future Pay-for-Delay Agreements

January 24, 2017

In a recent deal with the Federal Trade Commission, Endo agreed to refrain from entering into future pay-for-delay agreements for ten years.

Merck Settles Litigation with Bristol-Myers Squibb on Use of Antibody Targeting PD-1

January 24, 2017

Merck will pay a one-time fee of $625 million and additional royalties to BMS and Ono Pharmaceutical to settle the patent infringement case related to Keytruda.

The CRISPR Patent Debate

August 19, 2016

The legal battle between the Broad institute and UC Berkeley heated up after an email was released from a former graduate student.

US Patent Office Denies Amgen’s Petition to Review Humira Patents

January 15, 2016

The denial marks a setback for Amgen, who’s Humira biosimilar ABP 501 is the first submitted to FDA for adalimumab.

Protecting Intellectual Property in Packaging

April 30, 2015

Pharmaceutical companies should take into consideration intellectual property protection when outsourcing the packaging of their products.